MRC1 and cancer: To further investigate whether the observed changes in inflammasome activation in macrophages exposed to CM from LpOC01-SN-cured cancer cells were linked to a shift in macrophage phenotype, we assessed the expression of the M2 markers CD206 and CD163, known to be associated with a less inflammatory state and pro-tumorigenic activity [40].